Gain Therapeutics Inc. (GANX)
2.13
0.05 (2.40%)
At close: Jan 15, 2025, 3:59 PM
2.13
0.00%
After-hours Jan 15, 2025, 04:09 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 55.18K | 140.11K | 164.99K | 28.88K | 41.30K | 20.61K |
| Cost of Revenue | 80.38K | 64.17K | 7.16M | 2.26M | n/a | n/a |
| Gross Profit | -25.20K | 75.94K | -7.00M | -2.23M | 41.30K | 20.61K |
| Operating Income | -22.25M | -17.78M | -13.83M | -3.48M | -2.10M | -1.03M |
| Interest Income | 494.23K | 375.36K | 12.49K | 3.64K | 20.54K | n/a |
| Pretax Income | -22.19M | -17.50M | -13.89M | -3.57M | -2.19M | -1.10M |
| Net Income | -22.27M | -17.59M | -13.89M | -3.58M | -2.19M | -1.11M |
| Selling & General & Admin | 10.79M | 9.54M | 6.83M | 1.25M | 555.16K | 222.05K |
| Research & Development | 11.52M | 8.38M | 7.16M | 2.26M | 1.59M | 826.88K |
| Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 22.31M | 17.92M | 13.99M | 3.51M | 2.14M | 1.05M |
| Interest Expense | n/a | n/a | n/a | n/a | 20.54K | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 22.31M | 17.92M | 13.99M | 3.51M | 2.14M | 1.05M |
| Income Tax | 79.28K | 92.98K | 4.01K | 5.39K | 7.11K | 9.78K |
| Shares Outstanding (Basic) | 13.01M | 11.88M | 10.17M | 11.88M | 11.88M | 5.86M |
| Shares Outstanding (Diluted) | 13.01M | 11.88M | 10.17M | 11.88M | 11.88M | 5.86M |
| EPS (Basic) | -1.71 | -1.48 | -1.37 | -0.3 | -0.18 | -0.19 |
| EPS (Diluted) | -1.71 | -1.48 | -1.37 | -0.3 | -0.18 | -0.19 |
| EBITDA | -22.17M | -17.78M | -13.82M | -3.47M | -2.10M | -1.03M |
| Depreciation & Amortization | 83.58K | 64.17K | 15.48K | 9.59K | 2.57K | 741.00 |